Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 38 of 1714:
28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48
Gene Compound Assay Inh Ic50 Ki View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid A receptor, delta TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 TROPISETRON GABAA, Agonist Site 71% 3.025uM 2.395uM View
calcium channel, voltage-dependent, gamma subunit 8 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 7 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 6 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 5 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 4 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 3 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 2 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, gamma subunit 1 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
sodium channel associated protein 1 KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel associated protein 2 KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type III, beta KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type I, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type IX, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
sodium channel, voltage-gated, type VII, alpha KETOCONAZOLE Sodium Channel, Site 2 70% 23.911uM 21.438uM View
thromboxane A synthase 1 KETOCONAZOLE Thromboxane Synthetase 70% 2.165uM NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) KETOCONAZOLE Thromboxane Synthetase 70% 2.165uM NoneNone View
adrenergic receptor, beta 3 CIGLITAZONE Adrenergic beta3 70% 17.871uM 13.403uM View
aldo-keto reductase family 1, member B4 (aldose reductase) KETOROLAC Aldose Reductase 70% 6.109uM NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) KETOROLAC Aldose Reductase 70% 6.109uM NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) KETOROLAC Aldose Reductase 70% 6.109uM NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) KETOROLAC Aldose Reductase 70% 6.109uM NoneNone View
monoamine oxidase A NOCODAZOLE Monoamine Oxidase MAOA 70% 24.099uM NoneNone View
monoamine oxidase A NOCODAZOLE Monoamine Oxidase MAOA 70% 24.099uM NoneNone View
adenosine A2a receptor NOCODAZOLE Adenosine A2A 70% 7.509uM 4.219uM View
opioid receptor, sigma 1 PROGESTERONE Sigma1 70% 3.055uM 1.284uM View
adrenergic receptor, alpha 2a AMOXAPINE Imidazoline I2, Central 70% 3.466uM 2.31uM View
adrenergic receptor, alpha 2c (Non-specific probe) AMOXAPINE Imidazoline I2, Central 70% 3.466uM 2.31uM View
calcium channel, voltage-dependent, gamma subunit 8 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 7 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 6 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 5 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 4 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 3 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 2 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, gamma subunit 1 CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, beta 4 subunit CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
calcium channel, voltage-dependent, beta 3 subunit CLOTRIMAZOLE Calcium Channel Type L, Benzothiazepine 70% 28.499uM 25.332uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 BW-723C86 Serotonin Transporter 70% 4.785uM 2.542uM View
cholinergic receptor, muscarinic 3 SULOCTIDIL Muscarinic M3 70% 4.6238uM .98uM View
opioid receptor, sigma 1 DIMENHYDRINATE Sigma1 70% 1.158uM .487uM View
mu-opioid receptor MOR CINNARIZINE Opiate mu 70% 2.272uM .922uM View
opioid receptor, kappa 1 DOMPERIDONE Opiate kappa 70% 6.994uM 2.798uM View
calcium channel, voltage-dependent, gamma subunit 8 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 7 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 6 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 5 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 4 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 3 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 2 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, gamma subunit 1 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, beta 4 subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
ATPase, Na+/K+ transporting, beta 2 polypeptide CLADRIBINE ATPase, Na+/K+ 13% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, beta 2 subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, alpha 1F subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 OXICONAZOLE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 OXICONAZOLE Muscarinic M5 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 OXYMETAZOLINE Calcium Channel Type L, Benzothiazepine 67% NoneNone NoneNone View
Cytochrom P450-2C19 monooxygenase FELODIPINE CYP450-2C19 Inhibition 67% NoneNone NoneNone View
dopamine receptor D3 CANDESARTAN Dopamine D3 67% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 RALOXIFENE Muscarinic M2 67% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B SB-203580 Serotonin 5-HT4 67% 10.553uM 1.759uM View
5-hydroxytryptamine (serotonin) receptor 4 SB-203580 Serotonin 5-HT4 67% 10.553uM 1.759uM View
adrenergic receptor, beta 2 ATENOLOL Adrenergic beta2 67% 14.634uM 10.061uM View
lymphocyte protein tyrosine kinase (mapped) CLOMIPHENE Protein Tyrosine Kinase, Lck 67% NoneNone NoneNone View
mu-opioid receptor MOR DROPERIDOL Opiate mu 67% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) ANTIMYCIN A CYP450-2C9 Inhibition 67% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 ANTIMYCIN A CYP450-2C9 Inhibition 67% NoneNone NoneNone View
neuropeptide Y receptor Y2 DIHYDROERGOCRISTINE MESYLATE Neuropeptide Y2 67% NoneNone NoneNone View
adrenergic receptor, beta 3 NELFINAVIR Adrenergic beta3 67% 34.08uM 25.566uM View
opioid receptor, sigma 1 STANOLONE Sigma1 67% NoneNone NoneNone View
leukotriene C4 synthase 6-METHOXY-2-NAPHTHYLACETIC ACID Leukotriene C4 Synthetase 67% 49.66uM NoneNone View
leukotriene C4 synthase 6-METHOXY-2-NAPHTHYLACETIC ACID Leukotriene C4 Synthetase 67% 49.66uM NoneNone View
adrenergic receptor, alpha 2a PROCHLORPERAZINE Imidazoline I2, Central 67% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) PROCHLORPERAZINE Imidazoline I2, Central 67% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) PENTAMIDINE Adrenergic alpha1D 67% NoneNone NoneNone View
Sigma-2 Receptor CYPROHEPTADINE Sigma2 67% NoneNone NoneNone View
opioid receptor, sigma 1 METOCLOPRAMIDE Sigma1 67% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B ECONAZOLE Serotonin 5-HT1B 67% 22.034uM 10.016uM View
Sigma-2 Receptor MICONAZOLE Sigma2 67% 3.305uM 2.034uM View
adrenergic receptor, alpha 2a KETOCONAZOLE Adrenergic alpha2A 67% 19.783uM 7.419uM View
progesterone receptor CIGLITAZONE Progesterone 67% 29.118uM 3.798uM View
progesterone receptor CIGLITAZONE Progesterone 67% 29.118uM 3.798uM View
thromboxane A synthase 1 AURANOFIN Thromboxane Synthetase 67% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) AURANOFIN Thromboxane Synthetase 67% NoneNone NoneNone View
opioid receptor, kappa 1 SULCONAZOLE Opiate kappa 67% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) 4-OCTYLPHENOL Protein Tyrosine Kinase, Lck 67% 22.054uM NoneNone View
acetylcholinesterase (YT blood group) 4-OCTYLPHENOL Acetylcholinesterase 67% 11.471uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase 4-OCTYLPHENOL Acetylcholinesterase 67% 11.471uM NoneNone View
calcium channel, voltage-dependent, beta 4 subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, beta 3 subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, beta 2 subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, alpha 1F subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, beta 1 subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 KETOTIFEN Calcium Channel Type L, Benzothiazepine 71% 2.305uM 2.049uM View
AT hook, DNA binding motif, containing 1 (DBSS) NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, theta NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, gamma 2 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, alpha 2 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, alpha 1 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, delta NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, gamma 1 NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
gamma-aminobutyric acid A receptor, pi NORETHINDRONE GABAA, Benzodiazepine, Central 71% 13.343uM 10.872uM View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PROPAFENONE Adrenergic, Norepinephrine Transporter 71% 3.016uM 2.991uM View
progesterone receptor STANOZOLOL Progesterone 71% 3.705uM .483uM View
progesterone receptor STANOZOLOL Progesterone 71% 3.705uM .483uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 SIBUTRAMINE Serotonin Transporter 71% 2.085uM 1.108uM View
calcium channel, voltage-dependent, gamma subunit 5 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 4 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 3 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 2 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, gamma subunit 1 RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, beta 4 subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
calcium channel, voltage-dependent, beta 3 subunit RALOXIFENE Calcium Channel Type L, Dihydropyridine 71% .388uM .249uM View
ATPase, Na+/K+ transporting, beta 1 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide CHLORMADINONE ACETATE ATPase, Na+/K+ 71% 4.5696uM NoneNone View
nuclear receptor subfamily 3, group C, member 1 CORTISONE ACETATE Glucocorticoid 71% 3.911uM 1.778uM View
5-hydroxytryptamine (serotonin) receptor 2B BENZBROMARONE Serotonin 5-HT2B 71% 1.804uM 1.148uM View
tachykinin receptor 2 FLUPHENAZINE Tachykinin NK2 71% 22.484uM 7.495uM View
Sigma-2 Receptor DOXEPIN Sigma2 71% 2.143uM 1.319uM View
mitogen activated protein kinase 1 DICUMAROL Protein Serine/Threonine Kinase, ERK2 71% 4.426uM NoneNone View
mitogen-activated protein kinase 1 DICUMAROL Protein Serine/Threonine Kinase, ERK2 71% 4.426uM NoneNone View
cholinergic receptor, muscarinic 5 HALOPERIDOL Muscarinic M5 71% 3.89uM 2.795uM View
opioid receptor, sigma 1 TRAZODONE Sigma1 71% 2.203uM .926uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, beta 1 subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 VALETHAMATE BROMIDE Calcium Channel Type L, Benzothiazepine 70% 3.389uM 3.013uM View
cytochrome P450, family 3, subfamily a, polypeptide 13 CLOSANTEL CYP450-3A4 Inhibition 70% 5uM NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 IDEBENONE CYP450-3A4 Inhibition 70% 7uM NoneNone View
Cytochrom P450-2D6 monooxygenase BAMBUTEROL CYP450-2D6 Inhibition 70% 2uM NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) LOSARTAN CYP450-2C9 Inhibition 70% 2.882uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 LOSARTAN CYP450-2C9 Inhibition 70% 2.882uM NoneNone View
adrenergic receptor, alpha 1a PROPAFENONE Adrenergic alpha1A 70% 6.147uM 2.488uM View
adrenergic receptor, alpha 2a DOMPERIDONE Adrenergic alpha2A 70% 2.74uM 1.027uM View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 IVERMECTIN Dopamine Transporter 70% 4.4552uM 3.5397uM View
calcium channel, voltage-dependent, gamma subunit 8 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 7 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 6 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 5 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 4 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 3 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide CLADRIBINE ATPase, Na+/K+ 13% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, gamma subunit 1 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, beta 4 subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, beta 3 subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, beta 2 subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, alpha 1F subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, beta 1 subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SPIRADOLINE Calcium Channel Type L, Benzothiazepine 70% 8.513uM 7.567uM View
adrenergic receptor, alpha 2a BUTENAFINE Adrenergic alpha2A 70% 3.6443uM 1.3666uM View